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INSIGHTS FROM MODEL SYSTEMS
Specificity in Transforming Growth Factor–b Signaling Pathways
C. J. Ring and K. W. Y. Cho
Department of Developmental and Cell Biology, University of California, Irvine
We have recently seen an explosion of information in
the transforming growth factor (TGF)–b field, and it is
remarkable to consider that the receptors and signal
transducers for the TGF-b superfamily were identified
only over the past several years. With at least 30 TGF-
b superfamily members, the diversity of biological pro-
cesses influenced by these cytokines is not a surprise;
however, we are now beginning to appreciate the com-
plexity of signaling, as the multiple layers of regulation
are revealed.
Members of the TGF-b superfamily of cytokines in-
fluence a diverse range of normal cellular processes, such
as the secretion of the extracellular matrix, cell adhesion,
cell proliferation, and apoptosis, and therefore are well
placed to effect the morphogenesis of tissues and organs
and even the overall body plan of a developing embryo.
In addition, alteration of TGF-b signaling has been
linked to various developmental abnormalities, cancer
progression, and other human disorders. The variety of
effects that have been attributed to TGF-b superfamily
members underscores the importance of TGF-b signaling
and highlights the question of how this ligand family
exerts specific effects, depending on the cellular context.
The ability of TGF-b superfamily members to direct
tissue morphogenesis is illustrated by the activities as-
sociated with the bone morphogenetic proteins (BMPs),
one major group within the superfamily (Hogan 1996).
BMPs were originally identified as molecules that could
induce ectopic bone formation and, as the name sug-
gests, are thought to affect bone morphogenesis. The
BMPs are heterogeneously expressed during skeletal de-
velopment, and, in both the mouse and human, muta-
tions in BMPs are associated with various chondrodys-
plasias (Hogan 1996; Massague 1998). In addition to
bone morphogenesis, TGF-b signaling appears to play
a role in vascular histogenesis. Mutations in either of
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two genes encoding receptors of the TGF-b pathway
have been linked to the autosomal dominant disorder
hereditary hemorrhagic telangectasia (HHT), which
presents with vascular malformations in the skin and
mucosa (McAllister et al. 1994; Johnson et al. 1996).
This link, together with the demonstration that these
receptors are predominantly expressed in vascular en-
dothelial cells, suggests that they are important in the
regulation of the TGF-b response during the develop-
ment and homeostasis of the vasculature.
Evidence from vertebrate and invertebrate systems
suggests that TGF-b signaling also plays a more global
role in the morphogenesis of the entire embryo. Here,
we focus primarily on experiments performed by use of
the frog Xenopus laevis, where classic models of pattern
formation during embryogenesis are being tested with
modern molecular tools (see sidebar). In Xenopus, as in
the mouse and the fruit fly Drosophila melanogaster,
TGF-b signaling, specifically that of the BMP ligands, is
thought to play an important role in the specification of
the dorsoventral axis of the embryo (DeRobertis and
Sasai 1996; Hogan 1996; Lawrence and Struhl 1996;
Harland and Gerhart 1997). The involvement of BMPs
in both bone morphogenesis and embryonic patterning
illustrates the ability of TGF-b ligands to elicit dif-
ferential responses, depending on the cellular context.
Thus, how signaling specificity is achieved is a central
question in the TGF-b field. At the receptor level and
both intra- and extracellularly, this pathway offers di-
versity and combination opportunities that are likely to
underlie the multifunctional nature of the TGF-b su-
perfamily. Thus, the purpose of this review is twofold:
by use of Xenopus as a model system, (1) to introduce
the reader to molecular embryogenesis and (2) to sug-
gest mechanisms whereby signaling specificity can be
achieved.
The TGF-b Signaling Pathway
The currently accepted model of the TGF-b signaling
pathway is shown in somewhat simplified form in figure
1. According to this model, signaling begins when a spe-
cific ligand binds to its cognate type II receptor, a serine/
threonine kinase, which then heterodimerizes with and
phosphorylates a distinct serine/threonine kinase, the
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Getting Organized
Classic embryological experiments using grafting techniques de-
fined a region of the embryo, known as the “organizer,” that
had the ability to induce and pattern competent tissue in a host
embryo, when transplanted ectopically. The search soon ensued
for molecules that could mimic the organizer’s effects. Modern
molecular embryologists have used the introduction of ectopic
genes into Xenopus embryos, by cytoplasmic RNA or DNA
injection, to identify the molecules involved in the organizer’s
activity. Xenopus oocytes or embryos can be injected at various
stages, depending on the needs of the particular experiment. A
molecule is said to have “organizer activity” when, after injec-
tion into the ventral side of the embryo, it can induce ectopic
neural and mesodermal tissues. In particularly dramatic cases,
ectopic tissues may even form an entire duplicated embryo, also
known as a “complete secondary axis.” In the example below,
embryos were injected ventrally at the four-cell stage with
BVg1, a TGF-b superfamily member, and a complete secondary
axis formed that included both head and trunk.
Dorsal injections can result in various phenotypes, ranging
from hyperdorsalization to complete ventralization, and are
rated by an established dorsoanterior index. Various permu-
tations of these standard injections can be performed. For ex-
ample, “secondary axis rescue” occurs when a molecule known
to induce secondary axes is coinjected, on the ventral side of
the embryo, with one thought to counteract its effects. If the
secondary axis is reduced or abolished, the second molecule is
said to “rescue” the secondary axis.
Figure 1 Schematic of the components of the TGF-b signal-
transduction pathway. Disorders associated with various components
of the pathway are indicated. P-smad  pathway-specific smad, and
I-smad  inhibitory smad.
type I receptor. This activated type I receptor, in turn,
phosphorylates one of several pathway-specific smad
proteins. The smads are intracellular signal transducers
of the TGF-b pathway, and they can be roughly cate-
gorized as (1) pathway-specific smads, including smads
1–3, 5, and 8, which are directly phosphorylated by type
I receptors; (2) common or shared smads (of which
smad4 is the only known member), which act in multiple
TGF-b–superfamily signaling pathways; (3) inhibitory
smads, such as smad6 and smad7, which block the trans-
duction of TGF-b signals. Once phosphorylated by its
cognate type I receptor, the pathway-specific smad be-
comes activated, permitting heterodimerization with a
common smad; the complex is then translocated to the
nucleus, where it effects transcription (Massague 1998;
Whitman 1998). The smads appear to bind DNA
through a conserved region known as the “MH1 do-
main,” and they activate transcription via a region
known as the “MH2 domain.” The smads also assemble
with nuclear transcription factors to affect target-gene
expression.
This model implies that specificity of TGF-b signaling
is dictated by the type I receptor and, by extension, the
particular pathway-specific smad that it activates. How-
ever, further modulation of signaling may occur within
the cell, via smad interaction with other factors and cross
talk with other signaling components (Chen et al. 1996;
Kretzschmar et al. 1997). In addition, there is evidence
that extracellular components, as well as accessory re-
ceptors, are important in the modulation of the TGF-b
response, thus providing another level of regulation (Mc-
Allister et al. 1994; DeRobertis and Sasai 1996; Marques
et al. 1997; Piccolo et al. 1997). Although this model
provides the beginnings of a molecular framework of
how TGF-b signaling occurs, our understanding of how
TGF-b superfamily members regulate cell-type–specific
transcriptional activation is incomplete.
Ligand Regulation of Response and the Morphogen
Hypothesis
During early Xenopus embryogenesis, the dorsal and
ventral domains of the mesodermal germ layer are
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thought to be determined by activin/BVg1 and BMP sig-
nals, respectively, both of which are members of the
TGF-b superfamily of cytokines (Harland and Gerhart
1997). However, if activin/BVg1 signals are responsible
for specifying the dorsal mesodermal domain, how are
the various dorsal cell types (such as notochord and
muscle cells) generated in response to a single ligand?
The answer may lie in the ability of TGF-b superfamily
members to act as morphogens—that is, as factors that
elicit differential, patterned responses within a tissue, in
accordance with the amount of ligand presented to the
cells within the tissue (Gurdon et al. 1994; Harland and
Gerhart 1997). For example, graded amounts of activin
have been shown to specify various mesodermal cell
types, with higher levels specifying the dorsal-most types
and lower levels specifying the more ventral types. At
the molecular level, high levels of activin can induce the
dorsal mesodermal marker goosecoid (gsc), and lower
levels of activin can induce the mesodermal marker
brachyury (Xbra). Similarly, BMP4, the vertebrate ho-
mologue of Drosophila decapentaplegic (dpp), also has
recently been shown to behave as a morphogen in Xen-
opus embryos (Dosch et al. 1997).
How Do Different Ligand Concentrations Dictate
Multiple Cell Fates in Responding Tissues?
Recruitment of heterogeneous type I and type II re-
ceptor combinations with distinct signaling capacities by
variation of concentrations of ligand, perhaps due to
varying dissociation constants (Kd) among the receptors,
provides a means by which variation could be achieved
by a single signaling molecule. For instance, activin can
form a complex with activin receptor (ActR)–IIB and
either the ActR-I or ActR-IB receptor, and each com-
bination yields a unique physiological outcome (Car-
camo et al. 1994; Armes and Smith 1997). However,
other mechanisms may account for these effects, since
differential responses also can be elicited by varying con-
centrations of a single type I receptor (Armes and Smith
1997). Consistent with these data, variations in type
I–receptor concentration also can elicit patterned re-
sponses in the Drosophila wing (Lecuit and Cohen
1998). In this case, a feedback loop involving dpp neg-
atively regulates the amount of receptor expression,
which, in turn, influences the effective range of the dpp
gradient.
Cells may also detect ligand concentration by reading
the total number of occupied receptors per cell, as has
been elegantly shown by Dyson and Gurdon (1998) for
the case of the ActR-IIB receptor in Xenopus blasto-
meres. These authors demonstrated that cells induce
Xbra expression at low levels of ActR-IIB occupancy
and gsc expression at high levels, rather than by reading
out a ratio of occupied to unoccupied receptors. Because
signaling specificity is thought to occur via type I recep-
tors, it is unclear how type II–receptor occupancy is in-
terpreted by the type I/II–receptor complex. However,
similar responses to increasing activin doses were elici-
ted in tissues overexpressing either ActR-I or ActR-IB
mRNA, leading Dyson and Gurdon to conclude that,
although signaling specificity is mediated by type I re-
ceptors, the identity of the type I receptor does not qual-
itatively influence the response to high or low ligand
concentrations. These data demonstrate that activin ex-
hibits properties of a morphogen in experimental situ-
ations, but it remains unclear whether activin functions
as a morphogen in vivo or, indeed, whether a gradient
of activin protein actually exists in the embryo. Using
a luciferase-reporter construct containing an activin-
responsive element, Watabe et al. (1995) demonstrated
that activin activity appeared to be equivalent in do-
mains of endogenous gsc and Xbra expression, implying
that levels of activin (or an activin-like molecule) are
equivalent throughout the embryo. These results suggest
that a gradient of activin concentration across the tissue
may not be solely responsible for the differential acti-
vation of these genes in vivo.
Binding of TGF-b ligands to their receptors can be
modulated, in some cases, by non–signal-transducing
accessory receptors. The transmembrane proteoglycan
betaglycan and the related cell-surface glycoprotein en-
doglin belong to this third class of receptors, which is
thought to indirectly effect TGF-b signaling by control-
ling access to the type I/II receptors (Massague 1998).
Both endoglin and betaglycan bind TGF-b, although
with lower affinity than the type II receptors, and both
have been shown to associate with type I and type II
receptors to form a multimeric receptor complex. The
role of betaglycan as a facilitator of the binding of TGF-
b to the signaling receptors is most evident with TGF-
b2. This TGF-b isoform exhibits a low affinity for type
I and type II receptors, but receptor binding and activity
can be augmented in the presence of betaglycan (Mas-
sague 1998). Endoglin, in contrast, does not bind TGF-
b2 but binds TGF-b1 and TGF-b3. Although its role in
the binding of TGF-b to signaling receptors is unclear,
endoglin has been demonstrated to have a functional
role in endothelial cells, since it has been identified as
the gene responsible for the autosomal dominant dis-
order HHT type I (McAllister et al. 1994). Interestingly,
mutations in activin receptor–like kinase (ALK) 1, a type
I cell-surface receptor for the TGF-b superfamily of li-
gands, are responsible for the similar disorder HHT type
II (Johnson et al. 1996). The physiological ligand for
ALK1 is still unknown, but the fact that mutations in
both endoglin and ALK1 give rise to similar human dis-
orders suggests that endoglin and ALK1 act in the same
pathway and that endoglin may facilitate ligand binding
to ALK1. A third possible member of this accessory-
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receptor type is dally, a Drosophila member of the ver-
tebrate glypican family of heparan sulfate–containing
integral membrane proteoglycans. In Drosophila, dally
has been linked genetically to dpp signaling, and mu-
tations in human glypican 3 are responsible for Simpson-
Golabi-Behmel syndrome in humans (Selleck 1999). Al-
though a biochemical interaction between dally/glypican
and dpp has not been described, these examples serve
to illustrate the importance of accessory receptors in the
regulation of TGF-b signaling.
Intracellular Mechanisms of TGF-b Regulation
Studies in Xenopus showed that overexpression of
smad2 or its carboxy-terminal half can mimic the meso-
derm-inducing effects of activin (Baker and Harland
1996; Graff et al. 1996), whereas overexpression of
smad1 or smad5 mimics the ventralizing effects of BMP4
(Thomsen 1996; Suzuki et al. 1997). These observations
suggest that different smads might transduce distinct
TGF-b–superfamily signals. Further studies in Xenopus,
with BMP2/4- and activin/BVg1-specific reporters, dem-
onstrated that the specificity of the ventral BMP2/4 sig-
nals is mediated intracellularly by smad1 and that of the
dorsal activin/BVg1 signals is mediated by smad2 (Can-
dia et al. 1997). Although the response of a given cell
to a particular TGF-b–superfamily signal is due in part
to the activation of a particular pathway-specific smad
in the cell, the question of how cells can respond dif-
ferentially to the same ligand, by activation of a path-
way-specific smad, still remains. Interestingly, ectopic ex-
pression of pathway-specific smads in Xenopus embryos
can recapitulate, in some respects, the differential tis-
sue inductions of varying concentrations of TGF-b–
superfamily ligands. For example, ectopic expression of
smad2 in prospective ectoderm is sufficient to induce
relatively ventral mesodermal markers (e.g., Xbra) at
low doses and dorsal markers (e.g., gsc) at high doses
(Baker and Harland 1996; Graff et al. 1996), suggesting
that the amount of smad2 activation by the receptor
complex can regulate which target genes are activated.
In these experiments, doses of smad2 that were high
enough to induce gsc also induced Xbra; however, as
noted by Artinger et al. (1997), doses of activin high
enough to induce gsc inhibit expression of Xbra, which
is induced by lower doses of activin. Thus, the effects
of a gradient of ligand stimulation may be more complex
than simple activation of a smad gradient.
Cellular responses to TGF-b superfamily members
also involve negative regulation by inhibitory smads.
The inhibitory smad6 and smad7 in vertebrates andDad
(daughters against dpp) in Drosophila participate in neg-
ative feedback loops that appear to regulate the intensity
or duration of the TGF-b response (Imamura et al. 1997;
Nakao et al. 1997; Tsuneizumi et al. 1997). The antag-
onism of the inhibitory smads appears to occur at the
level of phosphorylation of the pathway-specific smads,
with smad7 inhibiting TGF-b–mediated phosphoryla-
tion of smad2 and smad3 and with smad6 inhibiting the
phosphorylation of smad1 and smad2 but not of smad3.
This mechanism appears to involve the binding of the
inhibitory smad to the type I receptor, thus preventing
activation of the pathway by blocking the interaction of
the pathway-specific smad with the receptor (Imamura
et al. 1997; Nakao et al. 1997; Tsuneizumi et al. 1997).
Evidence also suggests that, at low levels, smad6 inhibits
smad1 by competing with smad4 for binding to acti-
vated smad1 (Hata et al. 1998). Thus, by attenuating
the response to TGF-b ligands, inhibitory smads may
be able to affect the gradient of TGF-b signals within a
tissue.
In addition to their ability to act as transcriptional
activators, smads can interact with other factors that
together serve to modulate a cell’s response to a partic-
ular ligand, thereby providing an additional level of reg-
ulation. In Xenopus, forkhead activin signal transducer
(Fast)–1, a winged helix/forkhead transcription factor,
and the related Fast-2 in mouse appear to be important
in the induction of the early mesoderm response genes
mix.2 and gsc, respectively (Chen et al. 1996; Labbe et
al. 1998). Both Fast-1 and Fast-2 can form a complex
with smad2 and smad4, positively regulating an activin/
TGF-b response element in the promoter of these tar-
get genes, in a ligand-dependent manner. Interestingly,
smad3, a pathway-specific smad that is closely related
to smad2, can block an activin/TGF-b–responsive gsc-
reporter construct in a dose-dependent manner in cells
transfected with Fast-2 and with smad2 and smad4
(Labbe et al. 1998). This inhibition appears to be me-
diated by the MH1 domain of smad3, possibly via its
interaction with a smad4 binding site in the gsc pro-
moter. Although the physiological relevance of such an
interaction is still unclear, the differential effect of the
related smad2 and smad3 suggests another mechanism
whereby diverse responses to TGF-b ligands could be
generated.
Extracellular Regulation of TGF-b Signaling
The classic experiments of Spemann and Mangold
(1924) demonstrated that, on transplantation to the ven-
tral side of the embryo, a region of dorsal mesoderm of
the amphibian embryo that they termed the “organizer”
was capable of inducing tissue normally specified as ep-
idermis to become neural with the appropriate pattern.
Furthermore, the organizer was capable of inducing
more dorsal mesodermal cell types, such as muscle in
more ventral tissue destined to become mesenchyme. Be-
cause the induction of an ectopic nervous system, as well
as the dorsalization of ventral mesoderm, was dependent
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Figure 2 A, Fate map of Xenopus embryo. Mesodermal deriv-
atives from the marginal zone are indicated. The dorsal-most meso-
derm includes the notochord (“Not”) and head mesoderm (including
the prechordal plate mesoderm). B, Model of embryonic patterning
in Xenopus, highlighting aspects involving TGF-b signaling. Inhibitory
signals from the organizer (chordin and noggin) antagonize signals
from BMPs, which are members of the TGF-b superfamily of cyto-
kines. BMPs are distributed broadly throughout adjacent regions of
the embryo, and their signals would block the induction of neural
tissues and dorsal mesoderm if the signals from the organizer were
not present.
on the presence of the organizer, ventral was assumed
to represent a “default” state, and signals from the or-
ganizer were assumed to be required in order to induce
and pattern neural and dorsal mesodermal tissues, pre-
sumably by positively activating specific signal-trans-
duction pathways. Recent experiments, however, have
challenged this dogma, suggesting that inhibitory signals
from the organizer are required in order to antagonize
the signals present in the ventral ectoderm and meso-
derm rather than positively acting through their own
receptors/signal transducers (see fig. 2). Our current un-
derstanding is that ventral signals mediated by BMP4
(but that are likely to involve BMP2 and BPM7 as well)
induce epidermis and that neural fate results when this
activity is relieved by extracellular antagonism from the
organizer-secreted molecules noggin and chordin (Wil-
son and Hemmati-Brivanlou 1995; Piccolo et al. 1996;
Zimmerman et al. 1996). Both noggin and chordin bind
BMP ligands directly with high affinity, presumably pre-
venting interaction with their receptors. Chordin is a
homologue of the Drosophila gene short gastrulation
(sog), which functions similarly in flies by sequestering
dpp and screw, another Drosophila BMP homologue
(DeRobertis and Sasai 1996; Nguyen et al. 1998). Nog-
gin has similar activity when injected into Drosophila
embryos, but an invertebrate homologue has not yet
been identified. The presence of secretable BMP antag-
onists in embryos, at the appropriate place and time,
suggests that they function in vivo to regulate the avail-
ability of BMP ligands, which ultimately results in the
differential regulation of BMP target genes.
The ability of the organizer to induce and pattern
ventral regions of the embryo may be related to the
ability of TGF-b ligands to function as morphogens,
which have the ability to elicit a differential pattern
within a tissue in response to their concentration gra-
dient. As was alluded to above, BMP4 recently has been
shown to behave as a morphogen in dorsoventral mes-
oderm patterning in Xenopus (Dosch et al. 1997), and
its homologue, dpp in Drosophila, previously had been
proposed to act as a morphogen in the fly embryo, as
well as in the wing imaginal disc (Lawrence and Struhl
1996). In the Xenopus model, BMP4 acts during dor-
soventral mesoderm patterning to specify more ventral
mesodermal cell fates with increasing concentrations.
However, whether graded levels of BMP4 (or another
BMP) protein exist in the embryo is not clear, since its
message appears to be uniform throughout the meso-
derm. An alternative, although not mutually exclusive,
possibility is that a gradient of secreted noggin and/or
chordin emanating from dorsal mesoderm attenuates
BMP4 activity by regulating the amount of available
BMP ligands in adjacent regions of the embryo. In fact,
there is evidence that noggin can create a gradient of
BMP4 activity, presumably because it antagonizes the
action of BMP4. This graded activity, rather than the
absolute concentration of BMP4 ligand, may be respon-
sible for the dorsoventral patterning of the mesoderm
(Dosch et al. 1997). By extension, chordin would be
assumed to function similarly in dorsoventral patterning.
It is important to keep in mind however, that the exis-
tence of a gradient of noggin or chordin protein has not
yet been demonstrated in vivo.
The identification of Xolloid, theXenopus homologue
of the Drosophila gene tolloid (tld), provides an example
of yet another level of extracellular regulation of BMP
signaling (Piccolo et al. 1997). Xolloid and tld belong
to the astacin family of metalloproteases, which also
include BMP1. In Drosophila, dpp interacts genetically
with tld, but the interaction is opposite to that of sog,
in that tld is required in order to increase the activity of
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dpp, whereas sog functions to inhibit dpp signaling
(Marques et al. 1997). Similarly, in Xenopus, Xolloid
can functionally antagonize chordin activity (Piccolo et
al. 1997). For example, when injected ventrally, chordin
can induce a secondary axis in Xenopus embryos (see
sidebar), presumably by its ability to block BMP sig-
naling. Xolloid can block the ability of chordin but,
interestingly, not of noggin, to induce a secondary axis
when they are coinjected ventrally. Biochemical data
from both Drosophila and Xenopus have demonstrated
that Xolloid and tld proteolytically cleave chordin and
sog, respectively, thus preventing their ability to block
BMP/dpp signaling (Marques et al. 1997; Piccolo et al.
1997).
Together, these data suggest the following model for
dorsoventral patterning by the organizer-secreted mol-
ecules chordin, noggin, and Xolloid inXenopus (fig. 2B).
The ventralizing activity of BMPs is blocked dorsally
within the organizer, by the binding of noggin and chor-
din to BMPs, thus preventing the BMPs from interacting
with their receptors and functionally resulting in the
specification of dorsal phenotypes. The action of chordin
(and possibly of noggin) can be blocked extracellularly
by proteolytic cleavage. The cleavage of chordin by Xol-
loid could serve to restrict the activity of chordin to the
dorsal region of the embryo, by preventing active chor-
din from diffusing into adjacent regions of the embryo.
Future Directions
Because the number of identified TGF-b ligands far
exceeds the number of identified receptors and signal
transducers, it appears that cells do not have the luxury
to respond to each ligand through a unique signal-trans-
duction pathway; yet, cells still are able to respond to
various TGF-b superfamily members in characteristic
ways. Thus, cells must take advantage of the multiple
combination opportunities available in this pathway, not
only to generate specific responses to a range of TGF-b
ligands but also to respond differently to the same ligand
as the cellular context changes. As we have illustrated,
the specificity of TGF-b signaling can be modulated at
various levels, but fundamental questions remain re-
garding many of the molecular interactions and their
role in signaling specificity. For example, although it is
well recognized that TGF-b signaling requires an active
heterotetrameric complex consisting of dimeric forms of
type I and type II receptors, multiple forms of hetero-
tetrameric receptor complexes potentially can be gen-
erated by various combinations of type I and type II
receptors, as has been suggested for the case of the ActR-
IIB receptor, which can function in association with ei-
ther ActR-I or ActR-IB to confer different cellular re-
sponses (Carcamo et al. 1994; Armes and Smith 1997).
Furthermore, although both type I and type II receptors
exist as dimers, whether each receptor type forms homo-
dimers exclusively or whether heterodimeric forms exist
is not clear.
At the intracellular level, our understanding of the
mechanisms by which smads control specific gene in-
duction is limited. For instance, smads have been shown
to have both intrinsic DNA-binding capability, as well
as transcriptional transactivation activity (Whitman
1998), but they also have been shown to associate with
various nuclear transcription factors, which together ef-
fect target-gene activation (Chen et al. 1996; Whitman
1998). Therefore, whether activation of smads is suffi-
cient in itself to activate target genes in vivo is uncertain,
as are the relative contributions of the smad DNA-bind-
ing domain and the transactivation domain, in the ac-
tivation of target genes. Furthermore, Tsukazaki et al.
(1998) recently showed that the regulation of the sub-
cellular localization of the pathway-specific smad smad2
is important in the transduction of TGF-b signals. The
FYVE-domain protein SARA (smad anchor receptor ac-
tivation) functions in this localization by regulating the
interaction of smad2 with the receptor complex at the
membrane and smad4 in the cytoplasm. These authors
propose that phosphorylation of smad2 by the type I
receptor results in dissociation from SARA, with a con-
comitant formation of a smad2/4 complex and nuclear
translocation. The mechanism by which smads are trans-
located to the nucleus, where they affect gene expression,
remains unknown. These and other issues remain to be
addressed, and we anticipate that, as in the past, the
conclusions from work with Xenopus will dovetail with
findings from other systems as these fundamental ques-
tions are answered.
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